BEREMAGENE GEPERPAVEC-SVDT: 67 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
67
Total FAERS Reports
0
Deaths Reported
7
Hospitalizations
67
As Primary/Secondary Suspect
First Report: 20230808 · Latest Report: 20250728
What Are the Most Common BEREMAGENE GEPERPAVEC-SVDT Side Effects?
#1 Most Reported
Pruritus
7 reports (10.4%)
#2 Most Reported
Drug ineffective
6 reports (9.0%)
#3 Most Reported
Wound infection
5 reports (7.5%)
All BEREMAGENE GEPERPAVEC-SVDT Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Pruritus | 7 | 10.5% | 0 | 0 |
| Drug ineffective | 6 | 9.0% | 0 | 0 |
| Pyrexia | 5 | 7.5% | 0 | 0 |
| Wound infection | 5 | 7.5% | 0 | 2 |
Who Reports BEREMAGENE GEPERPAVEC-SVDT Side Effects? Age & Gender Data
Gender: 52.7% female, 47.3% male. Average age: 21.0 years. Most reports from: US. View detailed demographics →
Is BEREMAGENE GEPERPAVEC-SVDT Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2023 | 2 | 0 | 0 |
| 2024 | 3 | 0 | 2 |
| 2025 | 8 | 0 | 2 |
What Is BEREMAGENE GEPERPAVEC-SVDT Used For?
| Indication | Reports |
|---|---|
| Epidermolysis bullosa | 67 |
Official FDA Label for BEREMAGENE GEPERPAVEC-SVDT
Official prescribing information from the FDA-approved drug label.